Glaucoma is considered a leading cause of irreversible blindness. This mostly happens through the effect on optic nerve that leads to its degeneration. However, new evidence suggests that the effect of glaucoma goes beyond that and extend to lateral geniculate and visual cortex. Neuronal damage happens through different mechanisms. In the meanwhile, the only proven therapy for to delay glaucoma progression is lowering ocular pressure. However, it is known that in some glaucoma patients, death of RGCs continues despite intraocular pressure (IOP reduction), therefore, new therapeutic management are being tested with promising results. These therapies are focusing on neuroprotection and aim to halt or even reverse the process of the disease.

Neuroprotezione nel Glaucoma. Glaucoma is considered a leading cause of irreversible blindness. This mostly happens through the effect on optic nerve that leads to its degeneration. However, new evidence suggests that the effect of glaucoma goes beyond that and extend to lateral geniculate and visual cortex. Neuronal damage happens through different mechanisms. In the meanwhile, the only proven therapy for to delay glaucoma progression is lowering ocular pressure. However, it is known that in some glaucoma patients, death of RGCs continues despite intraocular pressure (IOP reduction), therefore, new therapeutic management are being tested with promising results. These therapies are focusing on neuroprotection and aim to halt or even reverse the process of the disease.

Neuroprotection in Glaucoma

ABU OBIED, BASIL
2018/2019

Abstract

Glaucoma is considered a leading cause of irreversible blindness. This mostly happens through the effect on optic nerve that leads to its degeneration. However, new evidence suggests that the effect of glaucoma goes beyond that and extend to lateral geniculate and visual cortex. Neuronal damage happens through different mechanisms. In the meanwhile, the only proven therapy for to delay glaucoma progression is lowering ocular pressure. However, it is known that in some glaucoma patients, death of RGCs continues despite intraocular pressure (IOP reduction), therefore, new therapeutic management are being tested with promising results. These therapies are focusing on neuroprotection and aim to halt or even reverse the process of the disease.
2018
Neuroprotection in Glaucoma
Neuroprotezione nel Glaucoma. Glaucoma is considered a leading cause of irreversible blindness. This mostly happens through the effect on optic nerve that leads to its degeneration. However, new evidence suggests that the effect of glaucoma goes beyond that and extend to lateral geniculate and visual cortex. Neuronal damage happens through different mechanisms. In the meanwhile, the only proven therapy for to delay glaucoma progression is lowering ocular pressure. However, it is known that in some glaucoma patients, death of RGCs continues despite intraocular pressure (IOP reduction), therefore, new therapeutic management are being tested with promising results. These therapies are focusing on neuroprotection and aim to halt or even reverse the process of the disease.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

È consentito all'utente scaricare e condividere i documenti disponibili a testo pieno in UNITESI UNIPV nel rispetto della licenza Creative Commons del tipo CC BY NC ND.
Per maggiori informazioni e per verifiche sull'eventuale disponibilità del file scrivere a: unitesi@unipv.it.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14239/25008